• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Inflammation (1932); Reaction (2414); Patient Problem/Medical Problem (2688)
Event Date 02/08/2019
Event Type  Injury  
Manufacturer Narrative
Event date - month and year valid.If information is provided in the future, a supplemental report will be issued.
 
Event Description
The patient was treated venaseal.It was reported by the patient that wounds developed on their leg that are not healing.An ultrasound showed glue under the skin.The two sores were debrided by the treating physician but they are not healing.
 
Manufacturer Narrative
Additional information: patient¿s short saphenous vein (ssv) on left leg was treated.Procedure was uneventful.No deviations occurred during the procedure.The catheter tip was 5cm caudal to the sapheno femoral junction (sfj) and there was compression of the ssv as the catheter was withdrawn.Patient attended follow-up 4 days post procedure and was seen to have closure without any issues.Approximately 8 weeks post procedure the patient attended an appointment where an induration was observed around the entry site of the needle.It was reported to be approximately 1-2cm in diameter.The physician saw the patient 3 days later and probed the point with an 18-gauge needle to about 2cm finding no evidence of any foreign body reaction or tissue induration.No foreign body reaction was observed on ultrasonography.Patient was seen again 2 weeks later, and the area of induration was less but an area of firmness was still present.The patient returned approximately a week later and there was some indication of inflammation, so the patient was prescribed keflex.2 weeks post this appointment the patient returned to another follow-up appointment and it was reported that it appeared as if something was extruding from the skin and felt it was a foreign body and was hard and firm to the touch.The patient returned the next day and the reaction had gone from what was seen the previous day and was less than 1cm circumferentially.The patient is reported to be doing well and improving.It is believed this may be a delayed reaction to foreign body.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8444113
MDR Text Key139570652
Report Number9612164-2019-01006
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,other
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/22/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/25/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age65 YR
-
-